Lymphoproliferative disorders Clinical Trials

A listing of Lymphoproliferative disorders medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Illinois

Chicago Illinois

A clinical research study of INCB053914 for the treatment of Advanced Cancer

Chicago Illinois 60637

A Phase 1/Phase 2 clinical study for patients using brentuximab vedotin, rituximab and laboratory biomarker analysis

Chicago Illinois 60611

A Phase 1/Phase 2 clinical study for patients using brentuximab vedotin, rituximab and laboratory biomarker analysis

Massachusetts

Boston Massachusetts 02111

A Phase 1/Phase 2 clinical study for patients using brentuximab vedotin, rituximab and laboratory biomarker analysis

Minnesota

Rochester Minnesota 55905

A Phase 1/Phase 2 clinical study for patients with Lymphoma or Lymphoma or Chronic Lymphocytic Leukemia

New York

New York New York 10065

A clinical research study of allogeneic Epstein-Barr virus-specific cytotoxic T lymphocytes for the treatment of Leukemia, Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific or Unspecified Childhood Solid Tumor, Protocol Specific

New York New York 10065

A Phase 1/Phase 2 clinical study for patients with Lymphoma or Lymphoma or Chronic Lymphocytic Leukemia

New York New York 10065

Patients are needed to participate in a clinical research study evaluating EBV-specific T-cells for the treatment of Non-Hodgkin's Lymphoma or Epstein-Barr Virus

Rochester New York 14642

A Phase 1/Phase 2 clinical study for patients with Lymphoma or Lymphoma or Chronic Lymphocytic Leukemia

Ohio

Columbus Ohio 43210

A Phase 1/Phase 2 clinical study for patients with Lymphoma or Lymphoma or Chronic Lymphocytic Leukemia

Texas

Houston Texas

A clinical research study of INCB053914 for the treatment of Advanced Cancer

Australia

UPDATED

Parkville Victoria 3052

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Randwick New South Wales 2031

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

South Brisbane Queensland 4101

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Westmead 2145

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Austria

UPDATED

Graz 8036

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Innsbruck 6020

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Wien 1090

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Belgium

UPDATED

Brussels 1200

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Brussels 1020

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Ghent 9000

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Leuven 3000

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Liège 4000

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Czech Republic

UPDATED

Praha 5 150 06

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Denmark

UPDATED

Kobenhavn O 2100

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

France

UPDATED

Bordeaux 33076

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Lyon 69008

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Marseille cedex 5 13385

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Nantes cedex 1 44093

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Paris 75012

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

View More ▼

UPDATED

Paris 75019

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Germany

UPDATED

Berlin 13353

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Duesseldorf 40225

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Essen 45122

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Frankfurt 60590

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Hamburg 20246

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

View More ▼

UPDATED

Jena 07740

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Kiel 24105

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Munich 80337

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Munster 48149

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Tübingen 72076

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Ulm 89075

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Würzburg 97080

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Israel

UPDATED

Haifa 31096

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Jerusalem 91120

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Petah Tikva 49202

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Tel Aviv 64239

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Tel Hashomer 52621

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Italy

UPDATED

Bologna 40138

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

UPDATED

Genova 16147

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)